MarketCap
Facebook
X
Telegram
Country |
 China |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.1 B |
Market Cap[1] |
$ 26.6 B |
EBITDA (LTM) |
$ -214 M |
P/E (LTM) |
-163.9375 |
P/S (LTM) |
62.43537 |
EPS (LTM) |
-0.16 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Bio-Techne Corporation
TECH
|
$ 72.4 | 0.05 % | $ 11.3 B | Nasdaq Global Select Market,SPB |  USA |
 |
Tenax Therapeutics
TENX
|
$ 1.98 | 2.59 % | $ 77.7 M | Nasdaq Global Select Market | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 39.53 | 0.56 % | $ 45.3 B | NYSE |  Israel |
 |
TG Therapeutics
TGTX
|
$ 54.29 | 1.25 % | $ 7.83 B | Nasdaq Capital Market | USA |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 1.12 | 0.44 % | $ 119 M | Nasdaq Global Market |  Britain |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 8.91 | 0.54 % | $ 75.8 M | Nasdaq Global Select Market | USA |
 |
Trevi Therapeutics
TRVI
|
$ 13.91 | 0.99 % | $ 1.87 B | Nasdaq Global Market | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.63 | 0.11 % | $ 1.48 B | Nasdaq Global Select Market | USA |
 |
UroGen Pharma Ltd.
URGN
|
$ 41.4 | 2.1 % | $ 1.99 B | Nasdaq Global Select Market | Israel |
 |
United Therapeutics Corporation
UTHR
|
$ 541.7 | 5.44 % | $ 24 B | Nasdaq Global Select Market,SPB | USA |
 |
Vericel Corporation
VCEL
|
$ 40.15 | 1.8 % | $ 2.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 45.81 | 3.67 % | $ 3.6 B | Nasdaq Global Market,SPB | USA |
 |
Vir Biotechnology
VIR
|
$ 11.17 | 1.42 % | $ 1.55 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 29.94 | 0.36 % | $ 3.37 B | Nasdaq Capital Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 4.63 | 0.51 % | $ 273 M | Nasdaq Global Select Market,SPB | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 4.38 | 0.11 % | $ 46.7 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 19.4 | 2.16 % | $ 1.98 B | Nasdaq Capital Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 504.73 | 0.07 % | $ 129 B | Nasdaq Global Select Market,SPB | USA |
 |
Verastem
VSTM
|
$ 7.7 | 0.5 % | $ 534 M | Nasdaq Global Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.28 | 0.64 % | $ 10.7 M | Nasdaq Global Select Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 30.57 | 3.27 % | $ 121 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 2.45 | 1.31 % | $ 144 M | Nasdaq Global Select Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.78 | 0.9 % | $ 637 M | Nasdaq Global Select Market |  Singapore |
 |
Xenetic Biosciences
XBIO
|
$ 2.24 | 0.45 % | $ 3.81 M | Nasdaq Capital Market | USA |
 |
XBiotech
XBIT
|
$ 2.19 | 0.46 % | $ 66.8 M | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.15 | 4.38 % | $ 7.24 M | Nasdaq Capital Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 38.02 | 4.68 % | $ 3.01 B | Nasdaq Global Select Market |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 9.08 | 0.1 % | $ 1.46 B | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 2.83 | 1.0 % | $ 120 M | Nasdaq Capital Market | USA |
 |
Xencor
XNCR
|
$ 24.84 | 0.28 % | $ 1.84 B | Nasdaq Global Select Market,SPB | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 2.16 | 1.41 % | $ 1.45 B | Nasdaq Capital Market | Israel |
 |
22nd Century Group
XXII
|
$ 0.91 | 7.78 % | $ 168 K | NYSE American | USA |
 |
ММЦБ
GEMA
|
- | - | - | MOEX |  Russia |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 2.52 | 2.03 % | $ 181 M | Nasdaq Global Market | USA |
 |
Zoetis
ZTS
|
$ 69.69 | 0.85 % | $ 30.9 B | NYSE,SPB | USA |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | Russia |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Theravance Biopharma
TBPH
|
$ 17.03 | 0.03 % | $ 857 M | Nasdaq Global Select Market |  Cayman-islands |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
|
Forte Biosciences
FBRX
|
$ 76.99 | 0.03 % | $ 997 M | Nasdaq Capital Market | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.